One of the primary outcomes is the suppression of pro-inflammatory cytokines, such as TNF-α, IL-6, and NF-κB, which are downregulated, thereby reducing tissue destruction and limiting the progression of periodontitis. The gene discussed is IL6; the disease is periodontitis.